|
|||||
|
|
| The Dilemma of Target Delineation with PET/CT in Radiotherapy Planning for Malignant Tumors | |
| 引用本文： | Suyu Zhu Bingqlang Hu. The Dilemma of Target Delineation with PET/CT in Radiotherapy Planning for Malignant Tumors[J]. 中国肿瘤临床(英文版), 2007, 4(6): 428-432. DOI: 10.1007/s11805-007-0428-6 |
| 作者姓名： | Suyu Zhu Bingqlang Hu |
| 作者单位： | Suyu Zhu Bingqiang Hu Department of Radiation Oncology，the HuNan Province Cancer Hospital，Changsha 410013，China. |
| 摘 要： | Currently there are many unanswered questions concerning contouring a target with PET/CT in radiotherapy planning.Who should contour the PET volume-the radiation oncologist or the nuclear medicine physician?Which factors will contribute to the dual-observer variability between them?What should be taken as the optimal SUV threshold to demarcate a malignant tumor from the normal tissue?When the PET volume does not coincide with the local area CT findings,which portion should be contoured as the target?If a reginal lymph node draining area or a remote region is shown to be PET positive but CT negative,or PET negative but CT positive,how is the target identified and selected?Further studies concerning the relationship between PET/CT and the cancerous tissue are needed.The long-term clinical results showing an increased therapeutic ratio wil finaly verify the applicability of guidelines to contour the target with PET/CT in radiotherapy planning. |
| 关 键 词： | 恶性肿瘤 放射治疗 诊断 临床表现 |
| 收稿时间： | 2007-08-04 |
| 修稿时间： | 2007-08-07 |
The dilemma of target delineation with PET/CT in radiotherapy planning for malignant tumors |
|
| Suyu Zhu,Bingqiang Hu. The dilemma of target delineation with PET/CT in radiotherapy planning for malignant tumors[J]. Chinese Journal of Clinical Oncology, 2007, 4(6): 428-432. DOI: 10.1007/s11805-007-0428-6 | |
| Authors: | Suyu Zhu Bingqiang Hu |
| Affiliation: | Department of Radiation Oncology, the HuNan Province Cancer Hospital, Changsha 410013, China. |
| Abstract: | Currently there are many unanswered questions concerning contouring a target with PET/CT in radiotherapy planning.Who should contour the PET volume-the radiation oncologist or the nuclear medicine physician?Which factors will contribute to the dual-observer variability between them?What should be taken as the optimal SUV threshold to demarcate a malignant tumor from the normal tissue?When the PET volume does not coincide with the local area CT findings,which portion should be contoured as the target?If a reginal lymph node draining area or a remote region is shown to be PET positive but CT negative,or PET negative but CT positive,how is the target identified and selected?Further studies concerning the relationship between PET/CT and the cancerous tissue are needed.The long-term clinical results showing an increased therapeutic ratio wil finaly verify the applicability of guidelines to contour the target with PET/CT in radiotherapy planning. |
| Keywords: | PET/CT radiotherapy planning target delineation. |
| 本文献已被 CNKI 维普 万方数据 SpringerLink 等数据库收录！ | |